Author(s): Badrul Munir, Dewi Santosaningsih, Dwi Yuni Nur Hidayati, Tri Yudani Mardining Raras, Tommy A Nazwar, Sumarno Reto Prawiro

Email(s): badroel2007@ub.ac.id

DOI: 10.52711/0974-360X.2024.00670   

Address: Badrul Munir1,2*, Dewi Santosaningsih3,6, Dwi Yuni Nur Hidayati3, Tri Yudani Mardining Raras4, Tommy A Nazwar5, Sumarno Reto Prawiro3
1Doctor Biomedical Science Program, Faculty of Medicine, Brawijaya University, Malang 65145, Indonesia.
2Departement of Neurology, Faculty of Medicine, Brawijaya University - Dr. Saiful Anwar Hospital, Malang 65145, Indonesia.
3Department of Clinical Microbiology, Faculty of Medicine, Brawijaya University, Malang 65145, Indonesia.
4Department of Bio-Chemistry, Faculty of Medicine, Brawijaya University, Malang 65145, Indonesia.
5Departement of Neuro Surgery, Faculty of Medicine, Brawijaya University- Dr. Saiful Anwar Hospital, Malang 65145, Indonesia.
6Department of Clinical Microbiology, Dr. Saiful Anwar Hospital, Malang 65145, Indonesia.
*Corresponding Author

Published In:   Volume - 17,      Issue - 9,     Year - 2024


ABSTRACT:
Antigen 38(PstS-1), is a lipoprotein secreted by M. tb and capable of enhancing B and T cell responses with high specificity. Previous study of recombinantantigen 38(RecAg38) from Mycobacterium tuberculosis local strain showed high homology of M.tb. Epitope is playinga significant role in the diagnosis of TB and TB meningitis. Previous study, antigen 38 could be detected in liquor cerebrospinal (LCS) tuberculosis meningitis in children. The purpose of this study was to prove recombinant antigen 38 and epitope antigen 38 can induce IgG and IgM antibodies. RecAg38 was overexpressed in E. coli BL21-(DE-3) strains. The purity of antigen was verified using SDS-PAGE and Western Blot. Using bioinformatic two dominant epitope antigen 38 was identified: QGTIKTWDDPQIAALNPGVNLP and Both antigen 38 and two dominant epitopes were used to immunize mice. As many as 12 male mice were divided into two groups. Group 1 received 50ug/0,3ml Antigen 38 intra peritoneal, whereas group 2 received 50ug/0,3 ml epitope. Booster at week 2,3, and 4. Detection of antibodies was conducted using ELISA assay. The results showed that Ag38 rec as well as epitopes of Ag38 rec could induce the synthesis of antibody IgG and IgM. the highest OD (Optical Density) value of IgG and IgM antibodies was 3,508 and 1,368 upon induction with Ag38 protein. Groups with an antibody concentration of 1/1000 and an antigen concentration of 10ug/mL. The highest OD IgM antibodies it was 1,368 in the peptide epitope dominant group 2 with an antibody concentration of 1/5000 and an antigen concentration of 10ug/mL. The conclusion is that recombinant protein and epitope antigen 38 has capacity to induce IgG antibodies, IgM in in vivo a hence potential to be used as a marker tuberculosis diagnosis test and candidate a biomarker for the diagnosis of TB meningitis.


Cite this article:
Badrul Munir, Dewi Santosaningsih, Dwi Yuni Nur Hidayati, Tri Yudani Mardining Raras, Tommy A Nazwar, Sumarno Reto Prawiro. Detection of Recombinant Antigen 38 and Epitope Antigen 38 Antibody as Humoral Immune Response of Tuberculosis as a New Marker of Tuberculous Meningitis. Research Journal of Pharmacy and Technology. 2024; 17(9):4337-2. doi: 10.52711/0974-360X.2024.00670

Cite(Electronic):
Badrul Munir, Dewi Santosaningsih, Dwi Yuni Nur Hidayati, Tri Yudani Mardining Raras, Tommy A Nazwar, Sumarno Reto Prawiro. Detection of Recombinant Antigen 38 and Epitope Antigen 38 Antibody as Humoral Immune Response of Tuberculosis as a New Marker of Tuberculous Meningitis. Research Journal of Pharmacy and Technology. 2024; 17(9):4337-2. doi: 10.52711/0974-360X.2024.00670   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-9-31


REFERENCES:
1.    Nguyen DT. Agarwal S. Graviss EA. Trends of Tuberculosis Meningitis and Associated Mortality in Texas, 2010-2017, a Large Population-Based Analysis. PLoS One. 2019; 14(2): 1-11. doi:10.1371/journal.pone.0212729.
2.    Munir B. Rianawati SB. Sutanto H. Agus SU. Mortality of Central Nervous System Infection Adult Patients in Indonesia (Descriptive Study In A Tertier Referral Hospital). J Neurol Sci. 2017; 381. doi:10.1016/j.jns.2017.08.3383.
3.    Wilkinson RJ. et al.Tuberculous meningitis. Nat. Rev. Neurol.2017; 13(10): 581–598. doi: 10.1038/nrneurol.2017.120.
4.    Mohammed MS. Sultana GD. Utilization of Bedaquiline among Drug Resistant-Tuberculosis patients. Asian J Pharm Res. 2022; 12(1): 132-136.doi:10.52711/2231-5691.2022.00020
5.    Ssebambulidde K. Gakuru J. Ellis J. Cresswell FV.Bahr NC. Improving Technology to Diagnose Tuberculous Meningitis: Are We There Yet? Front Neurol. 2022; 13(May): 4–11.
6.    Pukazhvanthen P. Anbarasu D. Basirudeen SAK. Raja A. Singh M. Assessing Humoral Immune Response of 4 Recombinant Antigens for Serodiagnosis of Tuberculosis. Tuberculosis. 2014; 94(6): 622-633. doi:10.1016/j.tube.2014.09.006.
7.    Woldeamanuel YW. Girma B. A 43-year systematic review and meta-analysis: Case-fatality and risk of death among adults with tuberculous meningitis in Africa. J. Neurol. 2014; 261(5): 851–865. doi: 10.1007/S00415-013-7060-6/FIGURES/7.
8.    Singh S. Singh J. Kumar S. et al. Poor Performance of Serological Tests in the Diagnosis of Pulmonary Tuberculosis: Evidence From a Contact Tracing Field Study. PLoS One. 2012; 7(7): 1-9. doi:10.1371/journal.pone.0040213.
9.    Munir B. Yuni D. Hidayati N. NazwarTA. RarasTM. PrawiroSR. The Ag38-rec Mycobacterium tuberculosis Antigen as a New Candidate Marker for The Diagnostic of Tuberculosis Meningitis : In Silico Approach. Research J. Pharm. and Tech. 2023; 16(12): 1–7.
10.    VordermeierHM. HarrisD P.Moreno C. Singh M. Ivanyi J. The nature of the immunogen determines the specificity of antibodies and T cells to selected peptides of the 38 kDa mycobacterial antigen.International Immunology. 1995; 7(4): 559–566. doi: 10.1093/intimm/7.4.559.
11.    Hao X. et al.Characterization of antibody response against 16kD and 38kD of M. tuberculosis in the assisted diagnosis of active pulmonary tuberculosis. Ann. Transl. Med. 2020; 8(15): 945–945. doi: 10.21037/ATM-20-5476.
12.    Sai PP.Ramesh MP. Recombinant Peroxidase: Production and its Prospective Applications- A Review. Res J Pharm Tech. 2018; 11(7): 3186-3196.doi:10.5958/0974-360X.2018.00586.3
13.    Verma RK. Jain A. Antibodies to mycobacterial antigens for diagnosis of tuberculosis. FEMS Immunol. Med. Microbiol. 2007; 51(3): 453–461.doi: 10.1111/j.1574-695X.2007.00302.x.
14.    BothamleyGH.Epitope-specific antibody levels in tuberculosis: biomarkers of protection, disease, and response to treatment.Front. Immunol. 2014; 5(JUN). doi: 10.3389/FIMMU.2014.00243.
15.    Haldar S.et al.Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA Impacts the Rapid Diagnosis of Tuberculous Meningitis in Children.PLoS ONE. 2012; 7(9). doi: 10.1371/journal.pone.0044630.
16.    Daniel TM. JanickiBW.Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties.Microbiol. Rev.1978; 42(1): 84–113. doi: 10.1128/MR.42.1.84-113.1978.
17.    RarasTYM. Sholeh G. Lyrawati D. Salivary sIg-A response against the recombinant Ag38 antigen of Mycobacterium tuberculosis Indonesian strain.International Journal of Clinical and Experimental Medicine. 2014; 7(1): 129–135.
18.    Nurhidayati DY. Yuliati Y. Fahrinda A. Raras TYM. Sujuti H. Prawiro SR. Effect of Ag38kDa recombinant protein antibodies of Mycobacterium tuberculosis and Rifampicin on CD4 and CD8 lymphocytes: Ex vivo study. In: AIP Conf Proc. Indonesia: AIP Publishing; 2023.
19.    Budaya TN. Permatasari HK. Widodo N. Prawiro SR. The Evolution of Polyclonal Antibody from Specific Epitope 47kDA for Detection of Bladder Cancer. Asian Pacific J Cancer Prev. 2023; 24(9): 3155–64.
20.    Raras TYM. Lyrawati D. Cloning and expression of pab gene of M. tuberculosis isolated from pulmonary TB patient in E.coli DH5α. Med J Indones. 2011; 20(4): 247–54.
21.    Hidayat R.  Wulandari P. Enzyme Linked Immunosorbent Assay (ELISA) Technique Guideline. Biosci. Med.  J. Biomed. Transl. Res. 2021; 5(5): 447–453. doi: 10.32539/bsm.v5i5.228.
22.    Fleri W. Paul S. Dhanda SK. Mahajan S. Xu X. Peters B.et al.The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design. Front. Immunol. 2017; 8 (MAR). doi: 10.3389/FIMMU.2017.00278.
23.    Manojkumar R. Patle SHG. In-Silico Inhibition Studies of Phenothiazine Based Compounds on Quinolinic Acid Phosphoribosyltransferase (1QPQ) Enzyme as A Potent Anti-Tuberculosis Agent. Asian J Res Chem. 2011; 4(6): 990-996.
24.    Sriroopreddy R. Raghuraman P.  Reena R. Modeling and Docking Study of GABA-AT Protein in Mycobacterium tuberculosis - A Computational Approach. Res J Pharm Tech. 2018; 11(4): 1283-1288. doi:10.5958/0974-360X.2018.00238.X.
25.    Chikoti SP. Venkataswamy M. Gandla H. Pindrathi P. Sandhya MJB. Medicinal Plants used for the Treatment of Bacterial Meningitis. Res J Pharm Dos Forms Technol. 2019; 11(3): 239-244.doi:10.5958/0975-4377.2019.00040.5.
26.    Subramaniam S. Sangeetha D. Identification of New Inhibitor against Mycobacterium tuberculosis using Structure Based Drug Designing and Docking Studies. Res J Pharmacogn Phytochem. 2017; 9(3): 173-176. doi:10.5958/0975-4385.2017.00032.2.
27.    Khoirul A. Bobi P. Meike TK. Yuliati. Winarsih S. Raras TYM. Prawiro SR. Multi Epitopes Potential on Surface SARS-CoV-2 Protein as a Covid-19 Vaccine Candidate. Res J Pharm Technol. 2022; 15(4): 1437-2. doi:10.52711/0974-360X.2022.00238.
28.    Fan X. et al.Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis. Vaccine. 2021; 39(47): 6860–6865. doi: 10.1016/j.vaccine.2021.10.034.
29.    Morishita M. et al. Recent advances in immunological diagnosis for tuberculosis.Kekkaku. 1994; 69(2): 97–106.
30.    Raras TYM. Fahrinda A. Yuliati Y. Nurhidayati DY. Sujuti H. Prawiro SR. Immune Response Upon the Administration of Recombinant Protein Antibodies Ag-38 kDa Mycobacterium tuberculosisand Rifampicin ex-vivo.African J. Infect. Dis. 2022; 16(2):71. doi: 10.21010/AJID.V16I2.8.
31.    Amicosante M.et al.Evaluation of a novel tuberculosis complex-specific 34 kDa protein in the serological diagnosis of tuberculosis. Eur. Respir. J. 1995; 8(12): 2008–2014. doi: 10.1183/09031936.95.08122008.
32.    El-Masry S. El-Kady I. ZaghloulMH.Al-BadraweyMK.Rapid and simple detection of a Mycobacterium circulating antigen in serum of pulmonary tuberculosis patients by using a monoclonal antibody and Fast-Dot-ELISA.Clin. Biochem. 2008. 41(3): 145–151. doi: 10.1016/J.CLINBIOCHEM.2007.11.008.
33.    Hur Y. G.et al.Evaluation of antigen-specific immunoglobulin g responses in pulmonary tuberculosis patients and contacts. J. Clin. Microbiol. 53(3): 904–909. doi: 10.1128/JCM.03050-14.
34.    Dinnes J.et al.A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol. Assess. 2007; 11(3): 1–178. doi: 10.3310/HTA11030.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available